aTyr Pharma, Inc. (LIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1149678,
    "name": "aTyr Pharma, Inc.",
    "stock_name": "aTyr Pharma, Inc.",
    "full_name": "aTyr Pharma, Inc.",
    "name_url": "stocks-analysis/atyr-pharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.83",
    "chg": 0.12,
    "chgp": "17.35%",
    "dir": 1,
    "prev_price": "0.71",
    "mcapval": "535.01",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US0021202025",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "6.46 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/atyr-pharma-inc-1149678-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is aTyr Pharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atyr-pharma-inc-technically-bullish-or-bearish-3546450",
        "imagepath": "",
        "date": "2025-09-20 19:33:05",
        "description": "As of 12 September 2025, the technical trend for aTyr Pharma, Inc. has changed from mildly bullish to bullish. However, the overall stance remains mixed due to conflicting indicators. The MACD shows a mildly bearish signal on the weekly timeframe but is bullish on the monthly. The RSI is bullish on the weekly but has no signal on the monthly. Moving averages indicate a mildly bullish trend on the daily, while the Bollinger Bands and Dow Theory are bearish on both weekly and monthly timeframes. \n\nIn terms of performance, aTyr Pharma has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -70.99% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish but with weak strength due to the mixed signals from various indicators...."
      },
      {
        "title": "aTyr Pharma Hits 52-Week Low at $0.97 Amidst Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/atyr-pharma-hits-52-week-low-at-097-amidst-significant-decline-3531391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/aTyrPharmaInc_priceRelatedfactors_3531391.png",
        "date": "2025-09-18 13:15:46",
        "description": "aTyr Pharma, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, operating in the Pharmaceuticals & Biotechnology sector, faces financial challenges, including a high price-to-book ratio and negative return on equity, while maintaining a volatile market presence."
      },
      {
        "title": "aTyr Pharma Hits 52-Week Low at $1.00 Amidst Market Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/atyr-pharma-hits-52-week-low-at-100-amidst-market-struggles-3519580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/aTyrPharmaInc_priceRelatedfactors_3519580.png",
        "date": "2025-09-16 11:22:41",
        "description": "aTyr Pharma, Inc. has reached a new 52-week low of USD 1.00, reflecting a 47.41% decline over the past year. The company, with a market capitalization of USD 535 million, faces financial challenges, including a high price-to-book ratio and negative return on equity, amid ongoing industry volatility."
      }
    ],
    "total": 8,
    "sid": "1149678",
    "stock_news_url": "https://www.marketsmojo.com/news/atyr-pharma-inc-1149678"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is aTyr Pharma, Inc. technically bullish or bearish?

2025-09-20 19:33:05

As of 12 September 2025, the technical trend for aTyr Pharma, Inc. has changed from mildly bullish to bullish. However, the overall stance remains mixed due to conflicting indicators. The MACD shows a mildly bearish signal on the weekly timeframe but is bullish on the monthly. The RSI is bullish on the weekly but has no signal on the monthly. Moving averages indicate a mildly bullish trend on the daily, while the Bollinger Bands and Dow Theory are bearish on both weekly and monthly timeframes. In terms of performance, aTyr Pharma has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -70.99% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish but with weak strength due to the mixed signals from various indicators....

aTyr Pharma Hits 52-Week Low at $0.97 Amidst Significant Decline

2025-09-18 13:15:46

aTyr Pharma, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, operating in the Pharmaceuticals & Biotechnology sector, faces financial challenges, including a high price-to-book ratio and negative return on equity, while maintaining a volatile market presence.

aTyr Pharma Hits 52-Week Low at $1.00 Amidst Market Struggles

2025-09-16 11:22:41

aTyr Pharma, Inc. has reached a new 52-week low of USD 1.00, reflecting a 47.41% decline over the past year. The company, with a market capitalization of USD 535 million, faces financial challenges, including a high price-to-book ratio and negative return on equity, amid ongoing industry volatility.

View All News